Revised forecast
Fiscal year ending December 2026 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
An increase in sales is expected in the Mobility & Healthcare and Other businesses, which performed strongly in the first half. Although procurement and logistics costs are expected to rise due to the worsening situation in the Middle East, the Company expects to achieve its initial plan in terms of profit.
Loss on sale of investment securities was ¥414 million in the previous interim consolidated accounting period and — in the current interim consolidated accounting period.
| Item | Details |
|---|---|
| Net Sales | ¥91,000 million → ¥93,000 million（2.2％） |
| Operating profit | ¥18,500 million → ¥18,500 million |
| Ordinary income | ¥18,500 million → ¥18,500 million |
| Profit attributable to owners of the parent | ¥13,690 million → ¥13,690 million |
| Net income per share | 84.91 yen → 84.91 yen |
| Fiscal Period Covered | Fiscal year ending December 2026 |
| Period Covered | Full year |
| Previous-period results | Interim period of the fiscal year ended December 2025: sales of ¥41,714 million, operating income of ¥9,203 million, ordinary income of ¥9,270 million, interim net income attributable to owners of the parent of ¥6,881 million, and interim earnings per share of ¥42.48 |
| Reason for the revision | An increase in sales is expected in the Mobility & Healthcare and Other businesses, which performed strongly in the first half. Although procurement and logistics costs are expected to rise due to the worsening situation in the Middle East, the Company expects to achieve its initial plan in terms of profit. |
| Details and amount of extraordinary loss | Loss on sale of investment securities was ¥414 million in the previous interim consolidated accounting period and — in the current interim consolidated accounting period. |
| Dividend forecast revision | No revision |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.An increase in sales is expected in the Mobility & Healthcare and Other businesses, which performed strongly in the first half. Although procurement and logistics costs are expected to rise due to the worsening situation in the Middle East, the Company expects to achieve its initial plan in terms of profit.